Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals

doi:10.4254/wjh.v17.i9.110049

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

(44)

(34)

(0)

(9)

(1)

(881)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Sep 27, 2025; 17(9): 110049
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.110049

Table 4 Correlation of albumin-bilirubin score with other non-invasive tests for liver fibrosis

			APRI score	AST to ALT	FIB-4 index
ALBI	Baseline	Spearman’s rank correlation coefficient	0.435^b	0.299^b	0.543^b
	Baseline	P value	0.000	0.000	0.000
	After DAA	Spearman’s rank correlation coefficient	0.190^b	0.211^b	0.154^a
	After DAA	P value	0.004	0.001	0.019

^aP < 0.05, correlation is significant (2-tailed).

^bP < 0.01, correlation is significant (2-tailed).

ALBI: Albumin-bilirubin; DAA: Direct-acting antiviral agents; APRI: Aspartate aminotransferase to platelet ratio index; ALT: Alanine transaminase; AST: Aspartate transaminase; FIB-4: Fibrosis-4 index.

Full Size Table

Citation: Ewid M, Sherif H, Saquib N, Alammari AM, Ismail AAM, Alkahlot MH, Ahmed ZT, Al-Zabidi FZM, Al Mutiri N. Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals. World J Hepatol 2025; 17(9): 110049
URL: https://www.wjgnet.com/1948-5182/full/v17/i9/110049.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i9.110049

Ewid M, Sherif H, Saquib N, Alammari AM, Ismail AAM, Alkahlot MH, Ahmed ZT, Al-Zabidi FZM, Al Mutiri N. Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals. World J Hepatol 2025; 17(9): 110049 [PMID: 41024871 DOI: 10.4254/wjh.v17.i9.110049]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.